Liposomal Amphotericin B and Isavuconazole/Posaconazole in Br-IFD( Breakthrough Invasive Fungal Disease) in Patients With Malignant Hematological Diseases
N/A
This is a prospective, open label, controlled, single center real-world obs...
Status
Recruiting
Location
National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Hospital
Start Date
2025-05-19
Trial ID
NCT07135778
SCH708980 With and Without AmBisome for Visceral Leishmaniasis
PHASE1
Background:
\- Visceral leishmaniasis (VL) is an infection caused by paras...
Status
Withdrawn
Location
Kala-Azar Medical Research Center (KAMRC), Rambag Road
A Phase II, Multicentre, Randomized, Two-arm Blinded Study to Assess the Efficacy and Safety of Two LXE408 Regimens for Treatment of Patients With Primary Visceral Leishmaniasis
PHASE2
This is a phase II, multicentre, randomized, two-arm blinded study with an ...